表紙
市場調查報告書

全球癌症用認知式運算市場預測

Global Cancer Cognitive Computing Market Outlook 2022

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 397995
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
全球癌症用認知式運算市場預測 Global Cancer Cognitive Computing Market Outlook 2022
出版日期: 2016年11月01日內容資訊: 英文 88 Pages
簡介

本報告提供全球癌症用認知式運算市場相關調查分析,提供市場現狀與未來預測,市場動態,趨勢與發展,主要企業等系統性資訊。

第1章 分析師的見解

第2章 調查手法

第3章 癌症用認知式運算:概要

第4章 市場動態

  • 推動因素
  • 阻礙因素
  • 機會

第5章 癌症人口統計

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 癌症用認知式運算市場預測

  • 各地區

第7章 癌症用認知式運算的趨勢與發展

  • 癌症治療用行動腫瘤應用程式
  • 建立第三方的認知生態系統
  • 新興企業打入針對醫療的認知式運算

第8章 M&A,夥伴關係

第9章 企業簡介

  • Apple Inc.
  • IBM Corporation
  • Microsoft Corporation
  • Google Inc.
  • Lockheed Martin Corporation
  • GE Healthcare
  • CognitiveScale Inc.
  • Enterra Solutions, LLC
  • Saffron Technology, Inc.
  • Apixio, Inc.,
  • Alacris Theranostics GmbH
  • Palantir Technologies
目錄

The emergence of Cognitive Computing for Cancer has revolutionized the healthcare industry. This technique is allowing a previously unattainable level of personalized treatment options with efficiency and simplicity. Due to this ability, it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences.

The report, "Global Cancer Cognitive Computing Market Outlook 2022", provides an insight of the current and future prospective of this market. This report covers the major opportunities in this area, and the factors impacting the market growth. Furthermore, the report also provides insight regarding the trends persisting in the market.

Global as well as regional prevalence of cancer is also discussed in the report. This will help the reader to understand the potential of each region for cognitive computing for cancer. Moreover, the report also estimates the number of cancer specialty hospital in each region, with name of major hospitals. These hospitals could be the target for the incorporation of cancer cognitive computing solutions.

The report contains the Cancer Cognitive Computing market share of major regions, including North America, Europe, Asia-Pacific, and the Rest of the World. North America holds the largest market share, while Asia-Pacific is expected to witness highest growth in the coming years, i.e. 2016-2022. The major reasons for the high growth in Asia-Pacific are the ongoing researches in China and Japan, which is expanding cognitive computing applications to oncology. North America and Europe are expected to grow at a modest rate due to launch of new and innovative products in this market.

The last segment of the report is entirely devoted to profiling leading companies of the Cancer Cognitive Computing industry, including some major players like IBM, Microsoft, Google, Apple, Palantir, Palantir, Alacris, Enterra Solutions, GE Healthcare, etc. This segment provides access to the financials, product, services or technology portfolio, and recent developments of these companies. This segment also discusses the strengths and weaknesses of key players in this industry. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the global Cancer Cognitive Computing market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Cognitive Computing for Cancer: An Overview

4. Market Dynamics

  • 4.1 Drivers
    • 4.1.1 Increasing Adoption of Watson for Cancer Treatment
    • 4.1.2 Rise in Number of Collaborations to Ramp-up Cancer Treatment
    • 4.1.3 Ability of Cognitive Computing to Enhance the Efficiency and Effectiveness of Treatment
    • 4.1.4 Ability to Analyze Extensive Cancer & Genome Data
    • 4.1.5 Rising Incidences of Cancer
    • 4.1.6 Advancements in Cognitive Computing Platforms
    • 4.1.7 Bolstering Internet Speed
  • 4.2 Restraints
    • 4.2.1 High Cost for Cognitive Computing Systems
    • 4.2.2 Lack of Expertise for Cognitive Computing
  • 4.3 Opportunities
    • 4.3.1 Increasing Adoption of Cloud Based Technology
    • 4.3.2 Latin America & Africa Offers Array of Opportunities for Market Growth

5. Cancer Demographics

  • 5.1 North America
  • 5.2 Europe
  • 5.3 Asia Pacific
  • 5.4 Rest of the World

6. Cancer Cognitive Computing Market Outlook

  • 6.1 By Geography

7. Trends & Developments in Cancer Cognitive Computing

  • 7.1 Mobile Oncology App for Cancer Care
  • 7.2 Establishment of Cognitive Ecosystems of Third Party Organizations
  • 7.3 Start-ups Entering Cognitive Computing Specialized for Healthcare

8. Mergers, Acquisitions & Partnerships

9. Company Profiles

  • 9.1 Apple Inc.
  • 9.2 IBM Corporation
  • 9.3 Microsoft Corporation
  • 9.4 Google Inc.
  • 9.5 Lockheed Martin Corporation
  • 9.6 GE Healthcare
  • 9.7 CognitiveScale Inc.
  • 9.8 Enterra Solutions, LLC
  • 9.9 Saffron Technology, Inc. (A Subsidiary of Intel Corporation)
  • 9.10 Apixio, Inc.,
  • 9.11 Alacris Theranostics GmbH
  • 9.12 Palantir Technologies

List of Figures:

  • Figure 5-1: Global - Breakup of Cancer Prevalence by Region (%), 2015
  • Figure 5-2: Global - Breakup of Cancer Prevalence by Region (%), 2025
  • Figure 6-1: Global - Cancer Cognitive Computing Market (Billion US$), 2016 & 2022
  • Figure 6-2: Global - Cancer Cognitive Computing Market by Geography (%), 2016
  • Figure 9-1: Apple Inc. - Net Sales Breakup by Product (%), 2015
  • Figure 9-2: Apple Inc. - Net Sales Breakup by Geography (%), 2015
  • Figure 9-3: IBM Corporation - Revenue Breakup by Business Segments (%), 2015
  • Figure 9-4: IBM Corporation - Revenue Breakup by Geography (%), 2015
  • Figure 9-5: Microsoft Corporation - Revenue Breakup by Business Segments (%), 2015
  • Figure 9-6: Microsoft Corporation - Revenue Breakup by Geography (%), 2015
  • Figure 9-7: Google Inc. - Revenue Breakup by Business Segments (%), 2015
  • Figure 9-8: Google Inc. - Revenue Breakup by Geography (%), 2015
  • Figure 9-9: Lockheed Martin Corporation - Net Sales Breakup by Business Segments (%), 2015
  • Figure 9-10: Lockheed Martin Corporation - Net Sales Breakup by Geography (%), 2015
  • Figure 9-11: GE Healthcare - Revenue Breakup by Business Segments (%), 2015
  • Figure 9-12: GE Healthcare - Revenue Breakup by Geography (%), 2015

List of Tables:

  • Table 5-1: Global - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-2: Global - Cancer Incidences (Million), 2015 & 2025
  • Table 5-3: North America - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-4: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 5-5: US - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-6: US - Cancer Incidences (Million), 2015 & 2025
  • Table 5-7: Canada - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-8: Canada - Cancer Incidences (Million), 2015 & 2025
  • Table 5-9: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 5-10: Europe - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-11: UK - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-12: UK - Cancer Incidences (Million), 2015 & 2025
  • Table 5-13: France - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-14: France - Cancer Incidences (Million), 2015 & 2025
  • Table 5-15: Germany - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-16: Germany - Cancer Incidences (Million), 2015 & 2025
  • Table 5-17: Spain - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-18: Spain - Cancer Incidences (Million), 2015 & 2025
  • Table 5-19: Italy - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-20: Italy - Cancer Incidences (Million), 2015 & 2025
  • Table 5-21: Norway - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-22: Norway - Cancer Incidences (Million), 2015 & 2025
  • Table 5-23: Asia Pacific - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-24: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 5-25: India - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-26: India - Cancer Incidences (Million), 2015 & 2025
  • Table 5-27: China - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-28: China - Cancer Incidences (Million), 2015 & 2025
  • Table 5-29: Japan - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-30: Japan - Cancer Incidences (Million), 2015 & 2025
  • Table 5-31: Asutralia - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-32: Australia - Cancer Incidences (Million), 2015 & 2025
  • Table 5-33: New Zealand - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-34: New Zealand - Cancer Incidences (Million), 2015 & 2025
  • Table 5-35: Malaysia - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-36: Malaysia - Cancer Incidences (Million), 2015 & 2025
  • Table 5-37: Rest of the World - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-38: Rest of the World - Cancer Incidences (Million), 2015 & 2025
  • Table 5-39: Latin America - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-40: Latin America - Cancer Incidences (Million), 2015 & 2025
  • Table 5-41: Africa - Cancer Prevalence (Million), 2015 & 2025
  • Table 5-42: Africa - Cancer Incidences (Million), 2015 & 2025
  • Table 6-1: Global - Total Number of Major Cancer Specialty Hospitals
  • Table 6-2: North America - Total Number of Major Cancer Specialty Hospitals
  • Table 6-3: North America - Major Cancer Specialty Hospitals
  • Table 6-4: Europe - Total Number of Major Cancer Specialty Hospitals
  • Table 6-5: Europe - Major Cancer Specialty Hospitals
  • Table 6-6: Asia Pacific - Total Number of Major Cancer Specialty Hospitals
  • Table 6-7: Asia Pacific - Major Cancer Specialty Hospitals
  • Table 6-8: Rest of the World - Total Number of Major Cancer Specialty Hospitals
  • Table 6-9: Rest of the World - Major Cancer Specialty Hospitals
  • Table 9-1: Apple Inc. - Product Pipeline
  • Table 9-2: Apple Inc. - Key Financials (Million US$), 2013-2015
  • Table 9-3: IBM Corporation - Product Portfolio
  • Table 9-4: IBM Corporation - Key Financials (Million US$), 2013-2015
  • Table 9-5: Microsoft Corporation - Project Portfolio
  • Table 9-6: Microsoft Corporation - Product Pipeline
  • Table 9-7: Microsoft Corporation - Key Financials (Million US$), 2013-2015
  • Table 9-8: Google Inc. - Product Pipeline
  • Table 9-9: Google Inc. - Key Financials (Million US$), 2013-2015
  • Table 9-10: Lockheed Martin Corporation - Service Pipeline
  • Table 9-11: Lockheed Martin Corporation - Key Financials (Million US$), 2013-2015
  • Table 9-12: GE Healthcare - Service Portfolio
  • Table 9-13: GE Healthcare - Key Financials (Million US$), 2013-2015
  • Table 9-14: CognitiveScale Inc. - Services Portfolio
  • Table 9-15: CognitiveScale Inc. - Product Pipeline
  • Table 9-16: Enterra Solutions, LLC - Services Portfolio
  • Table 9-17: Saffron Technology, Inc. - Products & Services Pipeline
  • Table 9-18: Apixio, Inc., - Technology Pipeline
  • Table 9-19: Alacris Theranostics GmbH - Technology Portfolio
  • Table 9-20: Palantir Technologies - Service Pipeline